Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines.

Hourihane, Jonathan O'B; Byrne, Aideen M; Blümchen, Katharina; Turner, Paul J; Greenhawt, Matthew

Hourihane, Jonathan O'B; Byrne, Aideen M; Blümchen, Katharina; Turner, Paul J; Greenhawt, Matthew.

Hourihane JO; Paediatrics and Child Health, Royal College of Surgeons in Ireland and Children's Health Ireland, Dublin, Ireland. Electronic address: jonathanhourihane@rcsi.com.
Byrne AM; Children's Health Ireland and Trinity College Dublin, Dublin, Ireland.
Blümchen K; Children and Adolescent Medicine, Division of Allergology, Pneumology and Cystic Fibrosis, Goethe University Frankfurt, Frankfurt, Germany.
Turner PJ; National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Greenhawt M; Allergy and Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.

J Allergy Clin Immunol Pract ; 9(7): 2562-2566, 2021 07.

Article in English | MEDLINE | ID: covidwho-1213308

Subject(s)

Anaphylaxis; COVID-19; Drug Hypersensitivity; Anaphylaxis/epidemiology; COVID-19 Vaccines; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Hypersensitivity / COVID-19 / Anaphylaxis Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google